COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company ...

The government has moved to significantly speed up the manufacturing of new and investigational drugs by halving the time required to review related applications, a step aimed at accelerating drug ...

Amendment in NDCTR eases approvals by replacing prior permission with prior intimation: Dr Premnath Shenoy: Nandita Vijayasimha, Bengaluru Saturday, January 24, 2026, 08:00 Hrs [I ...

Centre amends NDCTR-2019 to ease rules for approval of new drugs & investigational new drugs: Gireesh Babu, New Delhi Friday, January 23, 2026, 08:00 Hrs [IST] The Union health mi ...

Company expands its ADC pipeline and patent estate for novel, differentiated ADCsNew pipeline candidate AKTX-102 leverages ...

The RET fusion-targeted therapy market is set for strong expansion, driven by growing awareness of the oncogenic role of RET ...

Picture this: a breast cancer diagnosis that once meant endless cycles of harsh chemotherapy, now shifting toward smarter, more targeted therapies that attack cancer cells while sparing healthy ones.

Starting soon, the 16th World ADC London (23rd–26th February), the longest-standing and pre-eminent ADC-focused forum in Europe, serves as the definitive one-stop shop for the European ADC community ...

Acute-on-chronic liver failure (ACLF) is a life-threatening syndrome characterized by systemic inflammation and immune dysregulation, in which ...

Prescribing information and clinical guidelines showed gaps in TB screening protocols for many recently approved targeted ...

The RET fusion-targeted therapy market is set for strong expansion, driven by growing awareness of the oncogenic role of RET gene fusions and encouraging clinical trial outcomes. With the approval ...

The FDA has accepted a New Drug Application (NDA) for Celcuity’s gedatolisib in hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2), PIK3CA wild-type advanced ...